Congress trades and big insider sales, sent the day they're filed. Free.
Open in TelegramOfficers, directors and 10% owners must report trades within two business days on SEC Form 4. INSIDER parses each filing's XML from EDGAR. By default only discretionary open-market purchases and sales are shown; grants, option exercises and tax withholding are one click away.
| Score | Actor | Security | Side | Value | Disclosed | Evidence |
|---|---|---|---|---|---|---|
| 0 | Kelly John AlexanderChief Financial Officer | Option exercise · 10b5-1 plan | M | — 3,888 sh |
| Jan 22, 2026 traded Jan 20, 2026 |
| 0 | Vanderhook ChristopherDirector, Chief Operating Officer, 10% Owner | Option exercise · 10b5-1 plan | M | — 12.5K sh | Jan 22, 2026 traded Jan 20, 2026 |
| 0 | McBee BranninChief Development Officer | Derivative conversion · 10b5-1 plan | C | — 25.0K sh | Jan 22, 2026 traded Jan 20, 2026 |
| 0 | McBee BranninChief Development Officer | Derivative conversion · 10b5-1 plan | C | — 1,000 sh | Jan 22, 2026 traded Jan 20, 2026 |
| 0 | Sheena JonathanDirector, CO-FOUNDER | Option exercise · 10b5-1 plan | M | — 191 sh | Jan 22, 2026 traded Jan 20, 2026 |
| 0 | Chapman Steven LeonardDirector, CEO AND PRESIDENT | Option exercise · 10b5-1 plan | M | — 3,386 sh | Jan 22, 2026 traded Jan 20, 2026 |
| 0 | McBee BranninChief Development Officer | Derivative conversion · 10b5-1 plan | C | — 3,000 sh | Jan 22, 2026 traded Jan 20, 2026 |
| 0 | McBee BranninChief Development Officer | Derivative conversion · 10b5-1 plan | C | — 8,335 sh | Jan 22, 2026 traded Jan 20, 2026 |
| 0 | McBee BranninChief Development Officer | Derivative conversion · 10b5-1 plan | C | — 102.8K sh | Jan 22, 2026 traded Jan 20, 2026 |
| 0 | Scimeca DarioGeneral Counsel and Secretary | Option exercise · 10b5-1 plan | M | — 14.9K sh | Jan 22, 2026 traded Jan 20, 2026 |
| 0 | Vanderhook TimothyDirector, CEO and Chairman, 10% Owner | Disposition to issuer · 10b5-1 plan | D | — 12.5K sh | Jan 22, 2026 traded Jan 20, 2026 |
| 0 | Amoroso MichaelDirector, President and CEO | Option exercise · 10b5-1 plan | M | — 37.1K sh | Jan 22, 2026 traded Jan 20, 2026 |
| 0 | O'Connor CaseyChief Legal Officer | Option exercise · 10b5-1 plan | M | — 13.6K sh | Jan 22, 2026 traded Jan 20, 2026 |
| 62 | Brakewood Harold EugeneChief Business Officer | Open-market purchase | BUY | $25K 5,250 sh | Jan 21, 2026 traded Jan 16, 2026 |
| 52 | Marantz Jing L.CHIEF MEDICAL OFFICER | Open-market sale | SELL | $258K 5,798 sh | Jan 21, 2026 traded Jan 16, 2026 |
| 48 | Ho JunlinGENERAL COUNSEL | Open-market sale | SELL | $357K 8,016 sh | Jan 21, 2026 traded Jan 16, 2026 |
| 48 | Qatanani MoCHIEF SCIENTIFIC OFFICER | Open-market sale | SELL | $374K 8,406 sh | Jan 21, 2026 traded Jan 16, 2026 |
| 48 | Small MartinCFO & Senior Managing Director | Open-market sale | SELL | $15.09M 12.9K sh | Jan 21, 2026 traded Jan 16, 2026 |
| 48 | Parlavecchio CarynCHRO | Open-market sale | SELL | $294K 6,600 sh | Jan 21, 2026 traded Jan 16, 2026 |
| 45 | Small MartinCFO & Senior Managing Director | Open-market sale | SELL | $9.54M 8,139 sh | Jan 21, 2026 traded Jan 16, 2026 |
| 45 | Small MartinCFO & Senior Managing Director | Open-market sale | SELL | $6.46M 5,514 sh | Jan 21, 2026 traded Jan 16, 2026 |
| 36 | Attal AlainDirector | Open-market purchase | BUY | $260K 12.0K sh | Jan 21, 2026 traded Jan 21, 2026 |
| 35 | Small MartinCFO & Senior Managing Director | Option exercise | M | $13.89M 27.0K sh | Jan 21, 2026 traded Jan 16, 2026 |
| 34 | Small MartinCFO & Senior Managing Director | Open-market sale | SELL | $590K 503 sh | Jan 21, 2026 traded Jan 16, 2026 |
| 33 | Harmon CyrusDirector | Open-market sale | SELL | $269K 10.0K sh | Jan 21, 2026 traded Jan 20, 2026 |
| 31 | Ways Douglas KirkDirector, Interim Chief Medical Officer | Option exercise | M | — 1,250 sh | Jan 21, 2026 traded Dec 11, 2025 |
| 30 | Weitzel Gregory ThomasCFO | Disposition to issuer | D | $113K 9,003 sh | Jan 21, 2026 traded Jan 16, 2026 |
| 30 | Wollin Robert JGENERAL COUNSEL AND SECRETARY | Tax withholding | F | $202K 27.2K sh | Jan 21, 2026 traded Jan 17, 2026 |
| 30 | Exicure HiTron Inc.10% Owner | Open-market sale | SELL | $1.16M 258.4K sh | Jan 21, 2026 traded Jan 21, 2026 |
| 29 | Selecky ChristobelDirector | Open-market sale · 10b5-1 plan | SELL | $250K 50.0K sh | Jan 21, 2026 traded Jan 16, 2026 |
| 27 | Fleming Gregory JDirector | Grant or award | A | — 214 sh | Jan 21, 2026 traded Jan 16, 2026 |
| 27 | Wollin Robert JGENERAL COUNSEL AND SECRETARY | Option exercise | M | — 50.0K sh | Jan 21, 2026 traded Jan 17, 2026 |
| 27 | Weitzel Gregory ThomasCFO | Grant or award | A | — 24.1K sh | Jan 21, 2026 traded Jan 16, 2026 |
| 27 | Macdonald AndrewSee Remarks | Option exercise | M | — 3,841 sh | Jan 21, 2026 traded Jan 16, 2026 |
| 27 | Krishnamurthy NikkiSVP and Chief People Officer | Option exercise | M | — 2,113 sh | Jan 21, 2026 traded Jan 16, 2026 |
| 27 | DeSantis Dean10% Owner | Other acquisition or disposition | J | $4.65M 120.0K sh | Jan 21, 2026 traded Jan 16, 2026 |
| 27 | Gerrity Robert WDirector, Chief Executive Officer | Open-market sale · 10b5-1 plan | SELL | $610K 31.5K sh | Jan 21, 2026 traded Jan 16, 2026 |
| 27 | DeSantis Deborah10% Owner | Other acquisition or disposition | J | $4.65M 120.0K sh | Jan 21, 2026 traded Jan 16, 2026 |
| 27 | Senn AndrewSVP, Strategy and Business Dev | Option exercise | M | — 630 sh | Jan 21, 2026 traded Jan 17, 2026 |
| 27 | Milmoe William H.10% Owner | Other acquisition or disposition | J | $4.65M 120.0K sh | Jan 21, 2026 traded Jan 16, 2026 |